Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

2nd EurocanPlatform Translational Research Course

20 - 24 Oct 2014
Hotel Porto Bay, Falesia, Portugal
New approaches and new partnership models for biomarker based clinical research
Dr Denis Lacombe, EORTC, Brussels, Belgium
New approaches and new partnership models for biomarker based clinical research ( Dr Denis Lacombe, EORTC, Brussels, Belgium )
6 Jan 2015
Biomarkers for early detection and risk of relapse in breast cancer
Prof Anne-Lise Børresen-Dale, The Norwegian Radium Hospital, Oslo, Norway
Biomarkers for early detection and risk of relapse in breast cancer ( Prof Anne-Lise Børresen-Dale, The Norwegian Radium Hospital, Oslo, Norway )
6 Jan 2015
The DNA damage response and cancer therapy
Dr Christopher Lord, The Institute of Cancer Research, London, UK
The DNA damage response and cancer therapy ( Dr Christopher Lord, The Institute of Cancer Research, London, UK )
6 Jan 2015
Aims and successes of the 2nd EurocanPlatform project translational research cou...
Christina von Gertten, Karolinska Institutet, Stockholm, Sweden
Aims and successes of the 2nd EurocanPlatform project translational research course ( Christina von Gertten, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015
Epigenome deregulation in cancer
Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, Fran...
Epigenome deregulation in cancer ( Dr Zdenko Herceg, International Agency for Research on Cancer (IARC), Lyon, France )
6 Jan 2015
Immunotherapy of cancer: recent progress and future challenges
Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden
Immunotherapy of cancer: recent progress and future challenges ( Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden )
6 Jan 2015
Reasons to attend the EurocanPlatform translational research course 2015
Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany
Reasons to attend the EurocanPlatform translational research course 2015 ( Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany )
6 Jan 2015
Hormone receptor function in breast cancer therapy
Dr Wilbert Zwart, Netherlands Cancer Instititute (NKI), Amsterdam, The Netherlan...
Hormone receptor function in breast cancer therapy ( Dr Wilbert Zwart, Netherlands Cancer Instititute (NKI), Amsterdam, The Netherlands )
6 Jan 2015
2nd EurocanPlatform translational research course is good for networking
Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal
2nd EurocanPlatform translational research course is good for networking ( Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal )
6 Jan 2015
The p-medicine project and personalised medicine
Prof Norbert Graf, Saarland University, Homburg, Germany
The p-medicine project and personalised medicine ( Prof Norbert Graf, Saarland University, Homburg, Germany )
6 Jan 2015
Biobanking biological materials and linkage to clinical information
Dr Peter Riegman, Erasmus Medical Center, Rotterdam, The Netherlands
Biobanking biological materials and linkage to clinical information ( Dr Peter Riegman, Erasmus Medical Center, Rotterdam, The Netherlands )
6 Jan 2015
Cancer cell models for improved therapies
Dr Mathew Garnett, Wellcome Trust Sanger Institute, Cambridge, UK
Cancer cell models for improved therapies ( Dr Mathew Garnett, Wellcome Trust Sanger Institute, Cambridge, UK )
6 Jan 2015
Future research perspectives: the relationship between academia and industry
Prof Gunnar Saeter, Oslo University Hospital, Oslo, Norway
Future research perspectives: the relationship between academia and industry ( Prof Gunnar Saeter, Oslo University Hospital, Oslo, Norway )
6 Jan 2015
Paediatric drug development and the importance of collaboration
Dr Giuseppe Barone, The Institute of Cancer Research, London, UK
Paediatric drug development and the importance of collaboration ( Dr Giuseppe Barone, The Institute of Cancer Research, London, UK )
6 Jan 2015
The role of health economics in cancer outcomes research
Prof Bengt Jönsson, Stockholm School of Economics, Stockholm, Sweden
The role of health economics in cancer outcomes research ( Prof Bengt Jönsson, Stockholm School of Economics, Stockholm, Sweden )
6 Jan 2015